Talis Biomedical Corp
Change company Symbol lookup
Select an option...
TLIS Talis Biomedical Corp
DVN Devon Energy Corp
BCX BlackRock Resources & Commodities Strategy Trust
BRKS Brooks Automation Inc
OPEN Opendoor Technologies Inc
ADI Analog Devices Inc
HD Home Depot Inc
SIEN Sientra Inc
APPF Appfolio Inc
TGI Triumph Group Inc
Go

Health Care : Health Care Equipment & Supplies | Small Cap Growth
Company profile

Talis Biomedical Corporation. (Talis) Is engaged in developing molecular diagnostic tests for infectious diseases at the point of care. The Company is focused on developing and commercializing products that are designed to enable molecular testing for infectious diseases and other conditions. Talis is developing the Talis One platform, a cloud-enabled molecular diagnostic platform. The Talis One platform comprises a compact instrument, single-use test cartridges and software, including a central cloud database, which work together and are designed to provide central laboratory levels of accuracy. The platform is designed for use in non-laboratory settings, such as physicians’ offices, hospital emergency departments, urgent care clinics, ambulatory surgery centers, assisted living facilities, and cancer treatment and dialysis centers. The Company is also developing Talis One tests for respiratory infections, infections related to women’s health and sexually transmitted infections.

Price
Delayed
$10.41
Day's Change
-0.07 (-0.67%)
Bid
--
Ask
--
B/A Size
--
Day's High
11.09
Day's Low
10.05
Volume
(Below Average)

Today's volume of 46,360 shares is on pace to be lower than TLIS's 10-day average volume of 74,683 shares.

46,360

Macy's to offer $500 mln of bonds due 2029

7:31 am ET March 2, 2021 (MarketWatch)
Print
	

(END) Dow Jones Newswires

March 02, 2021 07:31 ET (12:31 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.